We Develop Novel Therapies for Large Unmet Conditions

At Avivomed, we are focused on developing and commercializing next generation neuromodulaton technology platforms to treat patients suffering from chronic diseases.

About us

Avivomed is developing innovative neuromodulation therapy to treat unmet clinical needs impacting large patient populations.

Avivomed is based in the United States and Ireland.

 

Our Supporters

We are a team of engineers and product developers with extensive experience in
implantable medical devices who are partnering with leading physicians to solve burdening chronic conditions and are supported by venture partners with deep domain expertise.

Meet the Team

Steve Masson

Steve Masson

CEO and Co-Founder

Steve is an experienced senior executive with 40 years in the medical technology business, including over 30 years in active implantable devices. He has held senior management roles for over 25 years, and has served in general management, research and development, and operational positions in both venture capital funded startups and revenue-driven companies, such as Cordis, Ventritex, InnerPulse, and NeuroTronik.

Steve has extensive multidisciplinary technical expertise, as well as experience in operations, quality, and clinical and regulatory affairs. He has led the development of a wide variety of medical devices, including cardiac rhythm management devices, neuromodulation systems, mechanical circulatory assist systems, system support and diagnostic instruments, catheters, and other percutaneous devices.

Innovation has been a key driver in his career, including the miniaturization of novel implantable devices, and development of a unique neuromodulation therapy for heart failure. 

Throughout his career, Steve has developed over 30 US and foreign patents, holding 8 issued US patents. Steve graduated with a BS in Electrical Engineering, as well as graduate studies in electrical and biomedical engineering from the University of Miami.

Let’s Start Something new
Say Hello!